Related references
Note: Only part of the references are listed.Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong
Chris Ka Pun Mok et al.
RESPIROLOGY (2022)
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
Peter B. Gilbert et al.
SCIENCE (2022)
Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms
David J. Lynn et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19
Wey Wen Lim et al.
LANCET MICROBE (2021)
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19
Yun Kit Yeoh et al.
GUT (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action
Carlo Pifferi et al.
NATURE REVIEWS CHEMISTRY (2021)
Ethnicity Associations With Food Sensitization Are Mediated by Gut Microbiota Development in the First Year of Life
Hein M. Tun et al.
GASTROENTEROLOGY (2021)
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
David S. Khoury et al.
NATURE MEDICINE (2021)
Emerging concepts in the science of vaccine adjuvants
Bali Pulendran et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
Jackson S. Turner et al.
NATURE (2021)
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
Alejandro Jara et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Profound Treg perturbations correlate with COVID-19 severity
Silvia Galvan-Pena et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
SARS-CoV-2 variants of concern partially escape humoral but not T- cell responses in COVID-19 convalescent donors and vaccinees
Daryl Geers et al.
SCIENCE IMMUNOLOGY (2021)
Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection
Eric H. Y. Lau et al.
ECLINICALMEDICINE (2021)
The influence of the gut microbiome on BCG-induced trained immunity
Martin Strazar et al.
GENOME BIOLOGY (2021)
Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera
Ranawaka A. P. M. Perera et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2021)
Dominant gut Prevotella copri in gastrectomised non-obese diabetic Goto-Kakizaki rats improves glucose homeostasis through enhanced FXR signalling
Noemie Pean et al.
DIABETOLOGIA (2020)
Serological assays for severe acute respiratory syndrome coronavirus 2 (BARS-CoV-2), March 2020
Ranawaka A. P. M. Perera et al.
EUROSURVEILLANCE (2020)
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
Tao Zuo et al.
GASTROENTEROLOGY (2020)
Longitudinal analysis reveals transition barriers between dominant ecological states in the gut microbiome
Roie Levy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
The Impact of the Microbiome on Immunity to Vaccination in Humans
Sanne E. de Jong et al.
CELL HOST & MICROBE (2020)
Neonatal Exposure to Commensal-Bacteria-Derived Antigens Directs Polysaccharide-Specific B-1 B Cell Repertoire Development
J. Stewart New et al.
IMMUNITY (2020)
Influence of gut microbiota on mucosal IgA antibody response to the polio vaccine
Ting Zhao et al.
NPJ VACCINES (2020)
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction
Chee Wah Tan et al.
NATURE BIOTECHNOLOGY (2020)
NBZIMM: negative binomial and zero-inflated mixed models, with application to microbiome/metagenomics data analysis
Xinyan Zhang et al.
BMC BIOINFORMATICS (2020)
Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial
Yi Wan et al.
GUT (2019)
Role of the Microbiota in the Modulation of Vaccine Immune Responses
Annalisa Ciabattini et al.
FRONTIERS IN MICROBIOLOGY (2019)
Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans
Thomas Hagan et al.
CELL (2019)
The Prevotella copri Complex Comprises Four Distinct Clades Underrepresented in Westernized Populations
Adrian Tett et al.
CELL HOST & MICROBE (2019)
Relative abundance of Megamonas hypermegale and Butyrivibrio species decreased in the intestine and its possible association with the T cell aberration by metabolite alteration in patients with Behcet's disease (210 characters)
Jun Shimizu et al.
CLINICAL RHEUMATOLOGY (2019)
Bifidobacterium Abundance in Early Infancy and Vaccine Response at 2 Years of Age
M. Nazmul Huda et al.
PEDIATRICS (2019)
Early-Life Antibiotic-Driven Dysbiosis Leads to Dysregulated Vaccine Immune Responses in Mice
Miriam Anne Lynn et al.
CELL HOST & MICROBE (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Gut Microbial Metabolites Fuel Host Antibody Responses
Myunghoo Kim et al.
CELL HOST & MICROBE (2016)
TLR5-Mediated Sensing of Gut Microbiota Is Necessary for Antibody Responses to Seasonal Influenza Vaccination
Jason Z. Oh et al.
IMMUNITY (2014)
Stool Microbiota and Vaccine Responses of Infants
M. Nazmul Huda et al.
PEDIATRICS (2014)
Anti-inflammatory and metabolic actions of FXR: Insights into molecular mechanisms
Danielle A. A. Hollman et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
Gary D. Wu et al.
SCIENCE (2011)
Sutterella parvirubra sp nov and Megamonas funiformis sp nov., isolated from human faeces
Hiroshi Sakon et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2008)
FimH Adhesin of Type 1 Fimbriae Is a Potent Inducer of Innate Antimicrobial Responses Which Requires TLR4 and Type 1 Interferon Signalling
Ali A. Ashkar et al.
PLOS PATHOGENS (2008)